Skip to main content
RAPS Euro Convergence 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Expert
Learning Level: Expert
Learning Level: Foundational
Learning Level: Foundational
Learning Level: Intermediate
Learning Level: Intermediate
RAPS Focus
RAPS Focus
Networking Opportunity
Networking Opportunity
Ticketed Event
Ticketed Event
Student Focus
Student Focus

Kate Stockman

Kenvue

Kate Stockman is the Vice President Regulatory Affairs at Kenvue (formerly Johnson & Johnson Consumer Healthcare), the world’s largest pure play consumer healthcare company. She is responsible for the company’s EMEA regulatory organisation comprising ~130 colleagues across >100 markets, providing strategic and operational leadership. Kate has 20+ years of pharma/consumer healthcare experience having previously worked at GSK, AstraZeneca, Pfizer & Haleon in a variety of regional and global regulatory leadership roles across a broad range of therapeutic areas. She has a strong track record of success in product development, from concept and early clinical development through to registration and life-cycle management of Rx & OTC medicines, medical devices, dietary supplements, cosmetics & herbal medicines. Kate also has significant experience in Rx to OTC switch and business development, mergers and acquisitions, winning industry awards for her innovative regulatory strategies. Kate has a Ph.D. in Molecular Microbiology from Guys Dental Hospital, Kings College London.

Presentation(s):